Click any tag below to further narrow down your results
Links
OpenAI's revenue passed $10 billion in the three months ending in September, according to people familiar with the company's investor call. The growth was driven by demand for its latest AI software.
- Quarterly revenue reached $10 billion for the first time, up nearly 50% from the prior quarter.
- Revenue almost tripled compared with the same quarter a year earlier.
- Greg Brockman, Sarah Friar, and Thibault Sottiaux discussed the figures on a Tuesday investor call. The numbers are not public, per the sources.
Etched announced a working inference chip and over $1 billion in signed contracts after emerging from stealth with $800 million raised and a $5 billion valuation. Their rack-scale system, built on TSMC’s N4P process, is already running models like DeepSeek, Qwen and Llama, and production is ramping at new Taiwan and San Jose facilities.
- Etched has working A0 silicon on TSMC's N4P process and a rack-scale system already running DeepSeek, Qwen, Mamba and Llama models
- The company raised $800M total, including a $500M round in December at a $5B post-money valuation, backed by Peter Thiel, Karpathy, Hinton, Fei-Fei Li and major trading firms
- It has over $1 billion in signed customer contracts despite being just under three years old
- Etched is building out Taiwan production and a San Jose HQ (data center, test house, NPI lab) with a goal of gigawatt-scale manufacturing by 2027
Reflection AI will pay $150 million monthly from July 2026 through 2029 for Nvidia GB300 chips and hardware at SpaceX’s Colossus 2 data center, in a contract worth up to $6.3 billion and cancellable after three months with 90 days’ notice. The startup says this deal underpins its open-weight AI strategy, positioning it against closed labs like Anthropic and OpenAI.
- Reflection AI will pay SpaceX up to $6.3 billion ($150M/month, 2026-2029) for GB300 chip access at Colossus 2, but either party can cancel with 90 days' notice after the first quarter.
- Reflection is the first open-weight AI lab to land a compute deal in the same tier as Anthropic ($1.25B/month) and Google ($920M/month) with SpaceX.
- The Colossus facility was originally built for xAI, and its underused capacity is now being sold to outside labs since xAI's own projects have lagged.
OpenEvidence is an AI search tool for doctors that indexes only peer-reviewed journals and clinical guidelines. Clinicians verify their credentials to access aggregated, real-time research from sources like JAMA and NEJM, cutting down on AI hallucinations. The free, ad-supported platform has just closed a $200 million Series C round at a $6 billion valuation.
- OpenEvidence raised $200M just three months after its $210M Series B, hitting a $6B valuation
- It's a credential-gated AI search tool for doctors that only pulls from peer-reviewed sources like JAMA, NEJM, PubMed, CDC and FDA to avoid hallucinations
- It's explicitly not for patients—designed to help doctors stay current on unfamiliar diseases, treatments, or new protocols
- The platform is free and ad-supported